Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
Medical College of Wisconsin
Medical College of Wisconsin
Sellas Life Sciences Group
Roswell Park Cancer Institute
Sellas Life Sciences Group
Sellas Life Sciences Group
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
University of Nebraska
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Virginia Commonwealth University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Roswell Park Cancer Institute
University of Maryland, Baltimore
University of Maryland, Baltimore
M.D. Anderson Cancer Center
University of Texas Southwestern Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Gruppo Italiano Malattie EMatologiche dell'Adulto
M.D. Anderson Cancer Center
Montefiore Medical Center
Dartmouth-Hitchcock Medical Center
Dartmouth-Hitchcock Medical Center
University of California, San Francisco
National Cancer Institute (NCI)
Washington University School of Medicine
UNC Lineberger Comprehensive Cancer Center
Sanofi
Wake Forest University Health Sciences
Alliance for Clinical Trials in Oncology
Emory University
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Benovus Bio, Inc.
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
SWOG Cancer Research Network
SWOG Cancer Research Network
SWOG Cancer Research Network
H. Lee Moffitt Cancer Center and Research Institute